CWA
ABBV icon

Cypress Wealth Advisors’s AbbVie ABBV Stock Holding History

Cypress Wealth Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-4,822
Closed -$275K – 192
2016
Q1 		$275K Buy
+4,822
New +$269K 0.13% 141

Other funds holding ABBV

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Cypress Wealth Advisors's ABBV Position: Q2 2016 in Review

Cypress Wealth Advisors sold out of AbbVie (ABBV) in Q2 2016, closing a stake of 4,822 shares — an estimated $275K sold.

Cypress Wealth Advisors first reported a position in ABBV in Q1 2016 and held it in 1 quarter. The position peaked at $275K in Q1 2016. 1,634 funds tracked by Wall St. Rank hold ABBV as of Q2 2016.

  • Cypress Wealth Advisors reported no remaining AbbVie position as of Q2 2016 after selling out during the quarter.
  • Cypress Wealth Advisors sold 4,822 AbbVie shares in Q2 2016, an estimated $275K.
  • Cypress Wealth Advisors first reported a position in AbbVie in Q1 2016 and held it in 1 quarter.
  • Cypress Wealth Advisors's AbbVie position peaked at $275K in Q1 2016.
  • 1,634 funds tracked by Wall St. Rank held AbbVie as of Q2 2016.

Based on Cypress Wealth Advisors's 13F filing for Q2 2016, filed 16 Aug 2016.